Making the Switch: When Your Patient Can't Afford Insulin Making the Switch: When Your Patient Can't Afford Insulin
For many patients, analogue insulin is simply unaffordable, but using non-analogue insulin can get complicated. Dr Anne Peters shares her tips and tricks for making a safe transition.Medscape Diabetes &Endocrinology
Publication date: Available online 3 June 2020Source: Life SciencesAuthor(s): Wahid Ali Khan, Arshi Malik, Mohd. Wajid Ali Khan
Publication date: Available online 2 June 2020Source: Life SciencesAuthor(s): Ying Luo, Yue Tian, Chunrong Zhao
Publication date: Available online 1 June 2020Source: Life SciencesAuthor(s): Fatma M. Amin, Rania R. Abdelaziz, Mohamed F. Hamed, Manar A. Nader, George G.S. Shehatou
Publication date: Available online 1 June 2020Source: Life SciencesAuthor(s): Jing Zou, Kang-Cheng Liu, Wan-Peng Wang, Yi Xu
Analyst, 2020, Accepted Manuscript DOI: 10.1039/D0AN00681E, PaperJian Xu, Kangkai Xu, Yu Han, Di Wang, Xiao Li, Tao Hu, Hong Yi, Zhonghua Ni As a chronic disease, diabetes may result in serious complications that endanger the health and life of patients. Accurate and real-time detection of blood sugar levels is of great significance... The content of this RSS Feed (c) The Royal Society of Chemistry
Conclusion: Worst indicators among women receiving BF reflect social inequalities inherent in this most vulnerable group. The study also shows that BF is being targeted at the most vulnerabl e women.
Authors: Holm A, Swahn E, Lawesson SS, Gustafsson KM, Janzon M, Jonasson L, Lindahl TL, Alfredsson J Abstract )Several earlier studies have reported increased risk of bleeding in women with myocardial infarction, (MI) compared to men. The reasons for the observed difference are incompletely understood, but one suggested explanation has been excess dosing of antithrombotic drugs in women. The aim of this prospective observational study was to assess sex differences in platelet activity in patients treated with three different platelet inhibitors. We recruited 125 patients (37 women and 88 men) with MI, scheduled for...
Authors: Okay G, Bolukcu S, Durdu B, Gultepe BS, Tuncay İ, Koc MM Abstract We sought to characterize the causative pathogens of prosthetic joint infections (PJIs), evaluate the trends in microbial etiologies, and identify potential risk factors for PJI. This was a retrospective study analyzing 70 patients with PJI following 3,253 total joint arthroplasties between 2011 and 2017. Staphylococci were the most common cause of infection (52.9%). There was a significant trend in the percentage of carbapenem-resistant gram-negative bacilli (GNB) (increased to 66.7% in 2016 from 0.0% in 2011) (p=0.021). GNB and polymicrob...
Authors: Carrega G, Casalino-Finocchio G, Cavagnaro L, Felli L, Riccio G, Burastero G Abstract Long-term evaluation of prosthetic joint infection treated with two-stage revision. Retrospective analysis of 102 periprosthetic infections treated with two-stage revision from 2010 to 2012 in Albenga hospital, Italy. During the second stage, samples for microbiological tests were collected. Failure was defined as a persistence of infection during the second stage or as a relapse during follow-up. 102 cases (55 hip, 47 knee) were analyzed. Patients were evaluated for a median of 44 months. 8/102 (8%) had positive cultures...
Conditions: Type 2 Diabetes; NASH - Nonalcoholic Steatohepatitis; NAFLD Interventions: Device: Duodenal Mucosal Resurfacing (DMR) Procedure; Device: Sham Sponsor: Fractyl Laboratories, Inc. Not yet recruiting